TrialCancer2012

Clofarabine plus low-dose cytarabine followed by clofarabine plus low-dose cytarabine alternating with decitabine in acute myeloid leukemia frontline therapy for older patients.

Stefan Faderl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.